ストックスクリーナーアプリを入手
17.24
0.23%
0.04
アフターアワーズ：
17.27
0.03
+0.17%
前日終値:
$17.20
開ける：
$17.29
24時間の取引高:
239.92K
Relative Volume:
0.58
時価総額：
$6.16B
収益：
$5.21B
当期純損益:
$-211.00M
株価収益率:
-27.90
EPS:
-0.6179
ネットキャッシュフロー:
$861.30K
1週間 パフォーマンス:
+1.11%
1か月 パフォーマンス:
+7.82%
6か月 パフォーマンス:
-3.90%
1年 パフォーマンス:
+18.90%
1日の値動き範囲:
$17.16
$17.45
1週間の範囲:
$16.77
$17.77
52週間の値動き範囲:
$13.77
$18.91
Bausch Lomb Corp Stock (BLCO) Company Profile
Compare BLCO vs ISRG, BDX, ALC, RMD, MDLN
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BLCO
Bausch Lomb Corp
|
17.24 | 6.14B | 5.21B | -211.00M | 861.30K | -0.6179 |
ISRG
Intuitive Surgical Inc
|
378.81 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
192.00 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
73.63 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
231.52 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
34.26 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-05 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2025-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2025-12-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-10-01 | 開始されました | Goldman | Neutral |
| 2025-05-02 | 繰り返されました | H.C. Wainwright | Buy |
| 2025-03-28 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-12-02 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-10-15 | アップグレード | Evercore ISI | In-line → Outperform |
| 2024-07-10 | 開始されました | Raymond James | Outperform |
| 2024-05-06 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-01-04 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2023-12-12 | 開始されました | Stifel | Hold |
| 2023-10-03 | 再開されました | Evercore ISI | Outperform |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-03-09 | 開始されました | Needham | Hold |
| 2022-12-21 | 開始されました | Barclays | Equal Weight |
| 2022-09-12 | 開始されました | H.C. Wainwright | Buy |
| 2022-07-26 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-06-24 | 開始されました | Evercore ISI | Outperform |
| 2022-06-06 | 開始されました | Citigroup | Buy |
| 2022-05-31 | 開始されました | Deutsche Bank | Hold |
| 2022-05-31 | 開始されました | Goldman | Neutral |
| 2022-05-31 | 開始されました | Guggenheim | Buy |
| 2022-05-31 | 開始されました | JP Morgan | Neutral |
| 2022-05-31 | 開始されました | Jefferies | Buy |
| 2022-05-31 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-05-31 | 開始されました | Wells Fargo | Overweight |
| 2022-05-11 | 開始されました | Cowen | Outperform |
すべてを表示
Bausch Lomb Corp (BLCO) 最新ニュース
Trading (BLCO) With Integrated Risk Controls (BLCO:CA) - Stock Traders Daily
Bausch + Lomb: The Market Is Pricing The Balance Sheet, Not The Eye-Care Engine - Seeking Alpha
BLCO Stock Drops After-Hours — Bausch + Lomb Halts Glaucoma Eye Drop Program After Trial Failure - Stocktwits
Did Bausch + Lomb’s (BLCO) Board Overhaul Amid Weak Returns Just Shift Its Investment Narrative? - simplywall.st
Bausch + Lomb Corporation (BLCO) Stock Analysis: Eyeing a 9.24% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Citi Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Maintains Target Price $21 - 富途牛牛
Bausch + Lomb Director Robert J. Chersi Granted 11,776 RSUs Under 2022 Incentive Plan - Kalkine Media
Bausch & Lomb (BLCO) director Barbara Trebbi receives 11,776-share RSU award - Stock Titan
Bausch & Lomb (BLCO) files Form 3 for new director Barbara Trebbi - Stock Titan
Bausch & Lomb (BLCO) director awarded 11,776 RSU-based common shares - Stock Titan
Bausch & Lomb (BLCO) director receives 11,776 RSU equity grant as compensation - Stock Titan
Bausch & Lomb Corp (BLCO) adds director Robert J. Chersi in Form 3 filing - Stock Titan
Bausch & Lomb Corp (BLCO) director Thomas Appio reports holding 27,583 shares - Stock Titan
Why Could Bausch + Lomb (TSX:BLCO) Gain From Aging Demographics? - Kalkine Media
Senior VP Of Bausch + Lomb Sold 54% Of Their Shares - Moomoo
Bausch + Lomb (NYSE:BLCO) CAO Sells 52,900 Shares - marketbeat.com
Bausch & Lomb (BLCO) SVP Frederick Munsch sells 52,900 shares in August trade - Stock Titan
Is Bausch + Lomb’s Raised 2026 Outlook And Board Refresh Altering The Investment Case For BLCO? - simplywall.st
Form 8K Bausch & Lomb Corp For: 12 August By Investing.com - Investing.com South Africa
Bausch & Lomb Corp (BLCO) Director Andrew C. von Eschenbach Sells 18,559 Shares - GuruFocus
BLCO (BLCO) shareholder plans NYSE sale of 52,900 restricted shares - Stock Titan
Bausch + Lomb (NYSE:BLCO) Director Eschenbach Andrew Von Sells 12,500 Shares - MarketBeat
Bausch & Lomb (NYSE: BLCO) director sells 18,559 shares after board exit - Stock Titan
Insider Selling: Bausch + Lomb (NYSE:BLCO) Director Sells $100,458.22 in Stock - MarketBeat
BLCO | Bausch + Lomb Corporation FinancialsIncome Statement - Quiver Quantitative
BLCO shareholder plans $887,885 stock sale (NYSE: BLCO) - Stock Titan
Bausch + Lomb Corporation (BLCO): Growth Potential and Analyst Ratings Point to an 11% Upside - DirectorsTalk Interviews
Bausch + Lomb Updates Board, Reaffirms 2026 Guidance - VisionMonday.com
Bausch + Lomb Corporation $BLCO Shares Bought by Sei Investments Co. - marketbeat.com
Bausch + Lomb (BLCO) Q2 2026 Earnings Call Transcript - The Globe and Mail
Bausch Lomb (BLCO) investor plans sale of 12,500 common shares - Stock Titan
Bausch & Lomb Corp (BLCO) awards 16,778 performance-based shares to executive - Stock Titan
Bausch & Lomb (NYSE: BLCO) SVP earns PSUs for 9,091 shares - Stock Titan
Bausch & Lomb Corp (BLCO) EVP awarded 20,973 PSUs after targets met - stocktitan.net
Bausch & Lomb (NYSE: BLCO) CFO granted 50,335 performance-linked shares - Stock Titan
Bausch & Lomb (NYSE: BLCO) Surgical president earns 16,778-share PSU-based award - Stock Titan
Bausch & Lomb (NYSE: BLCO) CLO earns 33,557 performance-based shares - Stock Titan
Bausch & Lomb Corp (BLCO) CEO granted 281,879 PSUs tied to 2027 vesting - Stock Titan
Bausch & Lomb Corp SEC Filing (Aug 6, 2026) - Stock Titan
Bausch + Lomb appoints four directors, reaffirms 2026 guidance By Investing.com - Investing.com South Africa
Bausch Health CEO joins Bausch + Lomb board of directors By Investing.com - Investing.com South Africa
Bausch + Lomb Corporation - Baystreet.ca
Stocks in play: Bausch + Lomb Corporation - The Globe and Mail
Form 8K Bausch & Lomb Corp For: 6 August By Investing.com - Investing.com Nigeria
Bausch + Lomb Announces Board of Directors Changes, Effective August 5, 2026 - marketscreener.com
Bausch + Lomb Announces Board of Directors Update, Reaffirms Guidance - BioSpace
Bausch + Lomb appoints four directors, reaffirms 2026 guidance - Investing.com
Bausch Health CEO joins Bausch + Lomb board of directors - Investing.com
Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board - PR Newswire
HC Wainwright Reduces Earnings Estimates for Bausch + Lomb - MarketBeat
Brokers Offer Predictions for Bausch + Lomb Q1 Earnings - marketbeat.com
Bausch Lomb Corp (BLCO) 財務データ
収益
当期純利益
現金流量
EPS
2.27%
0.27%
大文字化:
|
ボリューム (24 時間):